PRRT2 and asthma: Furthermore, PLE treatment inhibited the expression of PKC (Figure 3(i)), p-PKC (Figure 3(j)), p65 (Figure 3(k)), p-p65 (Figure 3(l)), cPLA2 (Figure 3(m)), and p-cPLA2 (Figure 3(n)) (P < 0.05 or 0.01) significantly in OVA-induced asthma mouse lung tissues.